metronidazole + BQ10

Metronidazole + BQ10 appears to refer to a combination product containing metronidazole and an agent designated as "BQ10." Metronidazole is a well-established nitroimidazole antibiotic and antiprotozoal agent, used primarily for the treatment of anaerobic bacterial infections and certain protozoal infections. It acts by entering microbial cells, where it is reduced to active metabolites that disrupt DNA synthesis, leading to cell death[1][2]. The mechanism of action involves the formation of nitroso free radicals that damage helical DNA structure in susceptible organisms. The identity of "BQ10" is unclear from available sources. There are no widely recognized pharmaceuticals or supplements with this exact designation in major drug databases or clinical literature as of June 2025. If BQ10 refers to a specific compound (such as a code name for an investigational drug or supplement), further clarification would be required for accurate characterization.